”Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcriptional regulation (PNAS)” was published
March 27, 2014
0 Comment
Differential roles of epigenetic changes and Foxp3 expression in regulatory T cell-specific transcripti […]
Continue Reading →”Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans (PNAS)” was published
October 19, 2013
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immun […]
Continue Reading →Sugiyama to receive “JACI Young Investigator Award”.
July 09, 2013
Japanese Association of Cancer Immunology (JACI) announced that Mr. Daisuke SUGIYAMA (Experimental Immunology […]
Continue Reading →Prof. Sakaguchi was Elected to “Distinguished Professor”
June 26, 2013
Osaka University (President: Toshio HIRANO) elected Shimon SAKAGUCHI (Deputy Dorector of IFReC) to “Dist […]
Continue Reading →Construction of self-recognizing regulatory T ce”lls from conventional T cells by controlling CTLA-4 and IL-2 expression (PNAS)” was published
June 04, 2013
Yamaguchi.T et al. Construction of self-recognizing regulatory T cells from conventional T cells by controllin […]
Continue Reading →“T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. (Immunity)” was published
November 18, 2012
The transcription factor Foxp3 is essential for the development of regulatory T (Treg) cells, yet its expressi […]
Continue Reading →Shimon Sakaguchi, Elected by National Academy of Sciences.
May 02, 2012
National Academy of Sciences (NAS) elected Professor Shimon Sakaguchi of IFReC to the foreign associate of NAS […]
Continue Reading →Prof. Shimon Sakaguchi to receive the Japan Academy Prize.
March 13, 2012
Prof. Shimon SAKAGUCHI of IFReC won the Japan Academy Prize. The title for the prize is “Control of immu […]
Continue Reading →“Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphoma. (Blood)” was published
February 08, 2012
西川准教授のグループよりATLに対する免疫治療に重要なターゲット(NY-ESO-1, MAGE-A3, MAGE-A4)についての論文が Blood に掲載されました。 Nishikawa.H et al. Cance […]
Continue Reading →
